Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Silo Pharma, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (2) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | Other (1) | 820,911 | (3) | $ | 1.355 | $ | 1,112,334.41 | $ | 0.0001476 | $ | 164.19 | |||||||||||||
| Total Offering Amounts | $ | 1,112,334.41 | $ | 164.19 | ||||||||||||||||||||||
| Total Fees Previously Paid | — | — | ||||||||||||||||||||||||
| Total Fee Offsets | — | — | ||||||||||||||||||||||||
| Net Fee Due | $ | 164.19 | ||||||||||||||||||||||||
| (1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended (the “Securities Act”), based upon the average of the high and low prices for a share of the registrant’s common stock as reported on The Nasdaq Capital Market on August 15, 2024. |
| (2) | Pursuant to Rule 416 under the Securities Act, the shares of common stock offered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions. |
| (3) | Represents the resale of (i) 763,638 shares of common stock issuable upon exercise of the July 2024 Investor Warrants, and (ii) 57,273 shares of common stock issuable upon the exercise of the July 2024 Placement Agent Warrants. |
